HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.

AbstractBACKGROUND:
By using array comparative genomic hybridization (CGH), the increased copy number of CYP24 (which encodes vitamin D 24-hydroxylase) at 20q13.2 was previously reported, leading to the identification of CYP24 as a candidate oncogene in breast cancer. CYP24 leads to abrogate growth control mediated by vitamin D.
MATERIALS AND METHODS:
We examined CYP24 expression as well as VDR (vitamin D receptor) gene expression in 42 esophageal cancer cases using semi-quantitative RT-PCR assay. We induced CYP24 in seven esophageal cancer cell lines using 25-hydroxyvitamin D3 [25(OH)D3] and compared cell growth rate, measured using the 3-(4, 5-dimethylthiazol-2-y)-2, 5-diphenyltetrazolium bromide (MTT) assay system.
RESULTS:
The overall survival rate was significantly higher in 25 cases of lower CYP24 expression than 17 cases of higher CYP24 expression (P <0.05); on the other hand, 23 cases of low VDR expression had a poorer prognosis than 19 cases of high VDR expression. Moreover, we disclosed that the inverse correlation between CYP24 and VDR expression is significant in esophageal cancer cases (P <0.05). Furthermore, the cell growth evaluated by MTT assay was greatly increased in CYP24-induced and VDR-diminished cells than non-responding cells by 25(OH)D3 activity (P <0.01).
CONCLUSIONS:
Overexpression of the candidate oncogene CYP24 is inversely correlated to vitamin D receptor expression, and may play an important role in determination of the malignant potential of esophageal cancer.
AuthorsK Mimori, Y Tanaka, K Yoshinaga, T Masuda, K Yamashita, M Okamoto, H Inoue, M Mori
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 15 Issue 2 Pg. 236-41 (Feb 2004) ISSN: 0923-7534 [Print] England
PMID14760115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Calcitriol
  • Cytochrome P-450 Enzyme System
  • Steroid Hydroxylases
  • Vitamin D3 24-Hydroxylase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cytochrome P-450 Enzyme System (biosynthesis, pharmacology)
  • Esophageal Neoplasms (genetics, pathology)
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Receptors, Calcitriol (biosynthesis, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Steroid Hydroxylases (biosynthesis, pharmacology)
  • Survival Analysis
  • Tumor Cells, Cultured
  • Vitamin D3 24-Hydroxylase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: